Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

GNLB

Genelabs (GNLB)

Genelabs Technologies (MM)
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:GNLB
日付受信時刻ニュースソース見出しコード企業名
2009/01/0807 : 44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNLBGenelabs Technologies (MM)
2009/01/0807 : 43Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNLBGenelabs Technologies (MM)
2009/01/0807 : 43Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNLBGenelabs Technologies (MM)
2009/01/0807 : 38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNLBGenelabs Technologies (MM)
2009/01/0807 : 15Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNLBGenelabs Technologies (MM)
2009/01/0807 : 12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNLBGenelabs Technologies (MM)
2009/01/0807 : 05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNLBGenelabs Technologies (MM)
2009/01/0806 : 50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNLBGenelabs Technologies (MM)
2009/01/0806 : 46Edgar (US Regulatory)(25-NSE)NASDAQ:GNLBGenelabs Technologies (MM)
2009/01/0806 : 41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNLBGenelabs Technologies (MM)
2009/01/0806 : 31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNLBGenelabs Technologies (MM)
2009/01/0805 : 21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNLBGenelabs Technologies (MM)
2009/01/0803 : 34Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:GNLBGenelabs Technologies (MM)
2009/01/0722 : 59Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:GNLBGenelabs Technologies (MM)
2009/01/0722 : 50PR Newswire (US)GlaxoSmithKline Successfully Completes Tender Offer for Shares of Genelabs Technologies, Inc.NASDAQ:GNLBGenelabs Technologies (MM)
2008/12/3023 : 01Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:GNLBGenelabs Technologies (MM)
2008/12/3022 : 50PR Newswire (US)GlaxoSmithKline Reduces Minimum Tender Condition and Extends Tender Offer To Acquire Genelabs Technologies, Inc.NASDAQ:GNLB
2008/12/1523 : 00PR Newswire (US)GlaxoSmithKline Further Extends Tender Offer to Acquire Genelabs Technologies, Inc.NASDAQ:GNLBGenelabs Technologies (MM)
2008/12/1523 : 00PR Newswire (US)GlaxoSmithKline Further Extends Tender Offer to Acquire Genelabs Technologies, Inc.NASDAQ:GNLBGenelabs Technologies (MM)
2008/12/1522 : 57Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:GNLBGenelabs Technologies (MM)
2008/12/0823 : 24Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:GNLBGenelabs Technologies (MM)
2008/12/0823 : 11PR Newswire (US)GlaxoSmithKline Extends Tender Offer for Genelabs Technologies, Inc.NASDAQ:GNLBGenelabs Technologies (MM)
2008/12/0600 : 50Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:GNLBGenelabs Technologies (MM)
2008/12/0407 : 27Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:GNLBGenelabs Technologies (MM)
2008/12/0406 : 30PR Newswire (US)GlaxoSmithKline Announces Waiver of a Condition to the Tender Offer for Genelabs Technologies, Inc.NASDAQ:GNLBGenelabs Technologies (MM)
2008/12/0404 : 07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNLBGenelabs Technologies (MM)
2008/11/2120 : 00Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:GNLBGenelabs Technologies (MM)
2008/11/2020 : 00Edgar (US Regulatory)Written communication by the subject company relating to a third party tender offer (SC14D9C)NASDAQ:GNLBGenelabs Technologies (MM)
2008/11/1406 : 06Edgar (US Regulatory)Current report filing (8-K)NASDAQ:GNLBGenelabs Technologies (MM)
2008/11/1404 : 37Business WireGenelabs Reports Results for the Third Quarter and First Nine Months of 2008NASDAQ:GNLBGenelabs Technologies (MM)
 Showing the most relevant articles for your search:NASDAQ:GNLB

最近閲覧した銘柄